1. IBM Micromedex® with Watson
Clinical Decision Support and Patient Education
For Technology Partners

2. By 2020 29 hours ½ of the workday
Challenges with delivering effective care
By 2020
medical data is expected to double every 73 days3
45% of medicine is not evidence based1
29 hours
Approximate amount of time Doctors would have to read each workday to keep up with new professional insights2
½ of the workday
Primary care physicians spend nearly
6 hours interacting with the EHR
during and after clinic hours4
Sources: 1) ) J Med Libr Assoc Oct; 92(4): 429–437. How much effort is needed to keep up with the literature relevant for primary care? Available at: 3) 4. Tethered to the EHR: Primary Care Physician Work- load Assessment Using EHR Event Log Data and Time- Motion Observations
Watson Health © IBM Corporation 2019

3. DRAFT IBM Micromedex® Delivers.
Valuable information to standardize care across your organization through access to evidence-based guidelines and protocols
Information from international sources so you can independently assess the information to make informed treatment decisions from a single platform
Evidence-based knowledge to enable appropriate treatment decisions anytime, anywhere
Patient education in multiple languages to help patients participate in their healthcare
Micromedex® is a leader in evidence-based clinical content that improves clinical decision making and fosters patient engagement. Helps clinicians avoid adverse drug events and treatment errors, guides medication use policy, and enables actionable patient health education
Watson Health © IBM Corporation 2019. 

4. IBM Micromedex® A solid history of Longevity and Innovation.
Used by over 4,500 hospitals in 80+ countries
Used by governments and hospitals for years
Used in schools of pharmacy and academic centers internationally
Supports toxicology management in poison control centers around the world
CMS-named compendia since 2008
Content created and maintained using a NICE accredited editorial process
Contains in-depth information that clinicians may need for complicated cases
Quick access to evidence with the AI of Watson
Notes:
Use for customer-facing presentations.
Image and layout from the IBM Watson Health VBC deck
Facts are current as of 5/Oct, 2017 and approved
Watson Health © IBM Corporation 2019. 

5. The Micromedex difference, putting the power of AI to work for you
IBM Micromedex® with Watson™ 1 2
Trained by clinicians
Designed for you
Developed with the evidence of Micromedex. Regularly validated by IBM clinicians to answer more questions from an expanding source of evidence.
Provides more flexibility to type questions in a more natural and conversational way, for clear and concise answers. 3 4
Reliable evidence
Easily accessible
Accelerate your access to the evidence-based information you count on IBM Micromedex for.
Multiple delivery methods for online work from Micromedex or from within the EHR, help leap system constraints and deliver reliable access.
2- train tune cycle
Watson Health © IBM Corporation 2019

6. IBM Micromedex®
Getting Started

7. IBM Micromedex® can help you deliver more value
Rapidly expand technology platforms to include evidence-based information for provider care and patient education at relevant intersections and points of care.
Online Clinical Evidence
Deliver curated content in your web based application.
Includes an AI powered Watson Assistant to find the most relevant information, fast.
Key Offerings
IBM Micromedex with Watson, Clinical Knowledge
IBM CareNotes and Medication Essential Fact Sheets, Patient Education
IBM NeoFax and Pediatrics, treatment and enteral nutrition evidence for neonatal and pediatric patients
Integrated Clinical Evidence
Embed Micromedex evidence directly into a host Health Information System (HIS), web portal, or partner application.
Key Offerings
Integrated Watson Assistant
Integrated CareNotes
Integrated NeoFax and Pediatrics
Summary Drug, Disease, Lab evidence from HL7V3 Infobutton
Summary Drug Evidence for embedded Use
RED BOOK™ pricing data for embedded Use
Automated Screening Tools
Cloud or on-prem software services to provide medication screening based on patient specific information.
Key Offerings
EMR/Pharmacy System Support Package
Includes:
Drug Interaction Screening
IV Compatibility
Warning Labels
Drug Identification
Summary Drug Evidence
Medication Instructions
IBM Watson / © 2019 IBM Corporation

8. of patients are not getting recommended care1
Sources: 1) ) J Med Libr Assoc Oct; 92(4): 429–437. How much effort is needed to keep up with the literature relevant for primary care? Available at:
Q: How do I keep up with the vast amount of information that can help my patients?
A: With IBM Micromedex.
50%
of patients are not getting recommended care1
167 hours of weekly reading for a health professional to keep up with new professional insight2
CareNotes Comprehensive Library Educates a Broader Population
Sources: 1) ) J Med Libr Assoc Oct; 92(4): 429–437. How much effort is needed to keep up with the literature relevant for primary care? Available at:

9. Patients immediately forget
Q: How do I educate my population?
A: With IBM Micromedex CareNotes and Medication Essential Fact Sheets.
Care providers access multiple sources for patient education material. Inefficient workflow and education is inconsistent. CareNotes comprehensive library educates a broader population.
14,000+ titles
Written at 4-8th grade reading level
Stages of care from pediatric to geriatric
High risk and co-morbidities
Wellness information
Medication Education (standard and brief length)
Patients immediately forget
40-80%
of medical information they are told and ½ of the information they do remember is incorrect1
CareNotes Comprehensive Library Educates a Broader Population
1- Patients' memory for medical information, Roy P C Kessels, J R Soc Med May; 96(5): 219–222.

10. Q: How do I ensure safe and effective drug therapy for neonatal/pediatric patients?
A: With IBM NeoFax and Pediatrics.
Neonatal and pediatric patients are at increased risk for medication errors. Many drugs used are for off-label indications. NeoFax and Pediatrics provides age- and indication-specific, off-label focused drug information for the most vulnerable patient populations.
Neonatal- and pediatric- specific monographs
Age-and indication-specific drug dosing calculators
Enteral formula and human milk fortifier nutritional information
Pediatric patients are 3X
more likely to experience a medication error or adverse drug event1
CareNotes Comprehensive Library Educates a Broader Population
Source: 1)

11. 29 hours Q: How do automate medication screening for every patient?
A: With IBM EMR/Pharmacy System Support.
EMR Pharmacy System Support, helps reduce medication prescribing and administration errors to improve patient safety.
EMR or Partner Solution
Drug Interaction Screening
IV Compatibility
Labeled Warnings
Drug Identification
Summary Drug Evidence
Medication Instructions
Coming Soon: Drug code mapping for local trade names and generics
29 hours
Approximate amount of time Doctors would have to read each workday to keep up with new professional insights.1
CareNotes Comprehensive Library Educates a Broader Population
Source: 1) J Med Libr Assoc Oct; 92(4): 429–437. How much effort is needed to keep up with the literature relevant for primary care? Available at:

12. IBM Micromedex® can help you deliver more value
Partners can depend on IBM Watson Health to focus on core business.
Experienced Implementation & Education Teams
Dedicated implementation teams, experienced with delivering Micromedex offerings in Health Information System (HIS).
Robust training center to support user proficiency with direct access to eLearning tools, office hours and live webinars.
Reliable Product Support
Online Support requests are handled during business hours with responses to most requests sent within 1 to 2 days.
Product Support:
U.S. and Canada: for Product Technical Support
Global: for Product Technical Support
IBM Watson / © 2019 IBM Corporation

13. Legal Disclaimer © IBM Corporation 2019. All Rights Reserved.
The information contained in this publication is provided for informational purposes only. While efforts were made to verify the completeness and accuracy of the information contained in this publication, it is provided AS IS without warranty of any kind, express or implied. In addition, this information is based on IBM’s current product plans and strategy, which are subject to change by IBM without notice. IBM shall not be responsible for any damages arising out of the use of, or otherwise related to, this publication or any other materials. Nothing contained in this publication is intended to, nor shall have the effect of, creating any warranties or representations from IBM or its suppliers or licensors, or altering the terms and conditions of the applicable license agreement governing the use of IBM software.
References in this presentation to IBM products, programs, or services do not imply that they will be available in all countries in which IBM operates. Product release dates and/or capabilities referenced in this presentation may change at any time at IBM’s sole discretion based on market opportunities or other factors, and are not intended to be a commitment to future product or feature availability in any way. Nothing contained in these materials is intended to, nor shall have the effect of, stating or implying that any activities undertaken by you will result in any specific sales, revenue growth or other results.
Performance is based on measurements and projections using standard IBM benchmarks in a controlled environment. The actual throughput or performance that any user will experience will vary depending upon many factors, including considerations such as the amount of multiprogramming in the user's job stream, the I/O configuration, the storage configuration, and the workload processed. Therefore, no assurance can be given that an individual user will achieve results similar to those stated here.
All customer examples described are presented as illustrations of how those customers have used IBM products and the results they may have achieved. Actual environmental costs and performance characteristics may vary by customer.
IBM, the IBM logo, ibm.com, and Watson Health are trademarks of International Business Machines Corp., registered in many jurisdictions worldwide. Other product and service names might be trademarks of IBM or other companies. A current list of IBM trademarks is available on the Web at “Copyright and trademark information” at ibm.com/legal/copytrade.
Watson Health © IBM Corporation 2019